Cwm, LLC Biomea Fusion, Inc. Transaction History
Cwm, LLC
- $33.3 Billion
- Q3 2025
A detailed history of Cwm, LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Cwm, LLC holds 364 shares of BMEA stock, worth $582. This represents 0.0% of its overall portfolio holdings.
Number of Shares
364
Previous 18,733
98.06%
Holding current value
$582
Previous $34,000
97.06%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMEA
# of Institutions
98Shares Held
23.1MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$6.14 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.71 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.75 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.28 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.01 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $46.9M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...